ODTX · Odyssey Therapeutics, Inc.
$20.84
+0.12 (+0.55%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$985.68M
Shares
48.06M
Volume · Oct 5
171.79K
Avg daily vol (3M)
269.64K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$20.73
Open$20.67
Day$20.05–21.60
Available close range$15.56–28.76
Avg vol 30d334K
Short int2.2M · 4.6% float · 10.8d
Short vol76%
DataMay 2026–Oct 2026
Filing10-Q · Aug 6
The closing range uses available history since May 8, 2026; less than a full year is stored.
Up next
filed Aug 6, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
-100.0%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$310.57M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2,069.3%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
4.6%
Latest settlement · 10.8 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Limited
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−8%
below
RSI (14)
43
neutral
MACD trend
Negative
52-week position
39%
mid-range
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+59 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.60% of float · ▼ -0.0% MoM · 10.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
59 holders — 13F breadth
Squeeze score
73
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
70%
annualized · 1-yr
Max drawdown
−31%
past year
ATR
9.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−8%
Bearish
RSI (14)
43
Neutral
MACD trend
Negative
Bearish
52-week position
39%
Neutral
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+59 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.60% of float · ▼ -0.0% MoM · 10.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
59 holders — 13F breadth
Price context
position in its available closing range
Range low $16
Now $21 · 39%
Range high $29
vs 50-day avg -8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ODTX
this stock
Odyssey Therapeutics, Inc.
|
$985.68M | — | — | — | 4.6% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$133.37B | +11.3% | +46.2% | 30.7 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.13B | -4.8% | +20.8% | 19.5 | 2.5% |
|
MRNA
Moderna, Inc.
|
$79.40B | +544.3% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$61.25B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ODTX | +1.1% | -21.5% | — | -6.7% | — |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | +1.3% | -21.0% | — | -7.7% | — |